Titan Pharmaceuticals, Inc. Patent Applications Rejected
2 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-10-10: Application 18554731; Invention KAPPA-OPIOID RECEPTOR AGONIST IMPLANTS FOR TREATMENT OF PRURITUS; Applicant Titan Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2021-09-10: Application 17472502; Invention IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINE; Applicant Titan Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2023-10-10 | 18554731 | KAPPA-OPIOID RECEPTOR AGONIST IMPLANTS FOR TREATMENT OF PRURITUS | Titan Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20240226226A1 | Katherine BEEBE DEVARNEY Marc RUBIN Rajesh A. PATEL Sunil SREEDHARAN | United States United States United States United States | |
| 2021-09-10 | 17472502 | IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINE | Titan Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220241186A1 | Rajesh A. PATEL Louis R. BUCALO | United States United States | WESTERBERG, NISSA M |